{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:20:29Z","timestamp":1787800829956,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10620-026-09949-9","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:12:10Z","timestamp":1778472730000},"page":"4290-4297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Infectious Outcomes with Dupilumab Compared with Proton Pump Inhibitors and Topical Steroids in Eosinophilic Esophagitis: A Multi-cohort Propensity Matched Analysis"],"prefix":"10.1007","volume":"71","author":[{"given":"Ridhima","family":"Kaul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Baggott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Philpott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Jansson-Knodell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Beveridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"9949_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.14309\/ajg.0000000000003194","volume":"120","author":"ES Dellon","year":"2025","unstructured":"Dellon ES, Muir AB, Katzka DA, Shah SC, Sauer BG, Aceves SS et al. ACG clinical guideline: diagnosis and management of eosinophilic esophagitis. American Journal of Gastroenterology. 2025;120:31\u201359.","journal-title":"American Journal of Gastroenterology."},{"key":"9949_CR2","unstructured":"Kim HP, Dellon ES. An evolving approach to the diagnosis of eosinophilic esophagitis. Gastroenterol Hepatol (N Y). 2018 [cited 2026 Jan 27]. ;14:358"},{"key":"9949_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/DOTE\/DOAE110","author":"CA Beveridge","year":"2025","unstructured":"Beveridge CA, Hermanns C, Thanawala S, Chatterjee A, Sharma N, Vura NVRK et al. Predictors of persistent symptoms in eosinophilic esophagitis after remission: fibrostenosis, eosinophilia, anxiety, and depression. Diseases of the Esophagus. 2025. https:\/\/doi.org\/10.1093\/DOTE\/DOAE110.","journal-title":"Diseases of the Esophagus."},{"key":"9949_CR4","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1016\/j.cgh.2020.01.024","volume":"18","author":"EJ Laserna-Mendieta","year":"2020","unstructured":"Laserna-Mendieta EJ, Casabona S, Savarino E, Perell\u00f3 A, P\u00e9rez-Mart\u00ednez I, Guagnozzi D et al. Efficacy of therapy for eosinophilic esophagitis in real-world practice. Clinical Gastroenterology and Hepatology. 2020;18:2903-2911.e4.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9949_CR5","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S2468-1253(23)00204-2","volume":"8","author":"ME Rothenberg","year":"2023","unstructured":"Rothenberg ME, Dellon ES, Collins MH, Hirano I, Chehade M, Bredenoord AJ et al. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2023;8:990\u20131004.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"9949_CR6","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","volume":"387","author":"ES Dellon","year":"2022","unstructured":"Dellon ES, Rothenberg ME, Collins MH, Hirano I, Chehade M, Bredenoord AJ et al. Dupilumab in adults and adolescents with eosinophilic esophagitis. N Engl J Med. 2022;387:2317\u20132330.","journal-title":"N Engl J Med."},{"key":"9949_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jaci.2024.01.028","volume":"154","author":"M Maurer","year":"2024","unstructured":"Maurer M, Casale TB, Saini SS, Ben-Shoshan M, Gim\u00e9nez-Arnau AM, Bernstein JA et al. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials. Journal of Allergy and Clinical Immunology. 2024;154:184\u2013194.","journal-title":"Journal of Allergy and Clinical Immunology."},{"key":"9949_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.9","volume":"6","author":"MY Chuang","year":"2015","unstructured":"Chuang MY, Chinnaratha MA, Hancock DG, Woodman R, Biostats M, Wong GR et al. Topical steroid therapy for the treatment of eosinophilic esophagitis (eoe): A systematic review and meta-analysis. Clin Transl Gastroenterol. 2015;6:e82.","journal-title":"Clin Transl Gastroenterol."},{"key":"9949_CR9","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1007\/s10620-024-08487-6","volume":"69","author":"A Chatterjee","year":"2024","unstructured":"Chatterjee A, Chittajallu V, Ford A, Alchirazi KA, Nanah R, Mansoor E et al. Increased risk of herpes zoster infection in patients with celiac disease 50 years old and older. Dig Dis Sci. 2024;69:2922.","journal-title":"Dig Dis Sci."},{"key":"9949_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/CROCOL\/OTAG027","author":"MH Nanah","year":"2026","unstructured":"Nanah MH, Chatterjee A, Wehbe H, Regueiro M. Comparison of IBD-related outcomes in patients with obesity treated with glp-1 receptor agonists versus bariatric surgery. Crohns Colitis 360. 2026. https:\/\/doi.org\/10.1093\/CROCOL\/OTAG027.","journal-title":"Crohns Colitis 360"},{"key":"9949_CR11","first-page":"1","volume":"5","author":"A Ford","year":"2023","unstructured":"Ford A, Chittajallu V, Abraham Perez J, Martin S, Alkhayyat M, Dave M et al. Prevalence rates of pneumococcal vaccination in ibd and 30-day clinical outcomes in patients with ibd and pneumococcal disease stratified by receipt of pneumococcal vaccination: a multi-network study. Crohns Colitis 360 2023;5:1\u20134.","journal-title":"Crohns Colitis 360"},{"key":"9949_CR12","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.soard.2025.06.004","volume":"21","author":"V Aitharaju","year":"2025","unstructured":"Aitharaju V, Sierra L, Syed A, Flora B, Staneff E, Chatterjee A et al. Safety of bariatric surgery in HIV-positive patients on antiretroviral therapy. Surgery for Obesity and Related Diseases. 2025;21:1126\u20131130.","journal-title":"Surgery for Obesity and Related Diseases."},{"key":"9949_CR13","unstructured":"Real-world data for the life sciences and healthcare | TriNetX [Internet]. [cited 2026 Jan 27]. Available from: https:\/\/trinetx.com\/"},{"key":"9949_CR14","unstructured":"Case Studies & Publications - TriNetX [Internet]. [cited 2026 Jan 27]. Available from: https:\/\/trinetx.com\/real-world-resources\/case-studies-publications\/"},{"key":"9949_CR15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s10620-024-08283-2","volume":"69","author":"A Malik","year":"2024","unstructured":"Malik A, Liu BD, Zhu L, Kaelber D, Song G. A Comprehensive global population-based analysis on the coexistence of eosinophilic esophagitis and inflammatory bowel disease. Dig Dis Sci. 2024;69:892\u2013900.","journal-title":"Dig Dis Sci."},{"key":"9949_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2500\/aap.2023.44.230031","volume":"44","author":"J Brennan","year":"2023","unstructured":"Brennan J, Yamada K, Al-Shaikhly T, Ghaffari G. Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic. Allergy Asthma Proc. 2023;44:333\u2013339.","journal-title":"Allergy Asthma Proc."},{"key":"9949_CR17","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/apt.70053","volume":"61","author":"R Nanah","year":"2025","unstructured":"Nanah R, Jansson-Knodell C, Chatterjee A, Nanah R, Nanah MH, Almasri J et al. Women\u2019s health disorders in a coeliac disease population after diagnosis\u2014a nationwide cohort analysis. Aliment Pharmacol Ther. 2025;61:1603\u20131611.","journal-title":"Aliment Pharmacol Ther."},{"key":"9949_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0319400","author":"Q Liao","year":"2025","unstructured":"Liao Q, Pan H, Guo Y, Lan Y, Huang Z, Wu P. Comparative efficacy and safety of dupilumab versus newly approved biologics and JAKi in pediatric atopic dermatitis: A systematic review and network meta-analysis. PLoS One. 2025. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0319400.","journal-title":"PLoS One."},{"key":"9949_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.14309\/ajg.0000000000003465","volume":"120","author":"GR Lichtenstein","year":"2025","unstructured":"Lichtenstein GR, Loftus EV, Afzali A, Long MD, Barnes EL, Isaacs KL et al. ACG clinical guideline: Management of crohn\u2019s disease in adults. American Journal of Gastroenterology. 2025;120:1225\u20131264.","journal-title":"American Journal of Gastroenterology."},{"key":"9949_CR20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","volume":"120","author":"DT Rubin","year":"2025","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Barnes EL, Long MD. ACG clinical guideline update: Ulcerative colitis in adults. American Journal of Gastroenterology. 2025;120:1187\u20131224.","journal-title":"American Journal of Gastroenterology."},{"key":"9949_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS242015165","author":"G Marasco","year":"2023","unstructured":"Marasco G, Visaggi P, Vassallo M, Fiocca M, Cremon C, Barbaro MR et al. Current and novel therapies for eosinophilic gastrointestinal diseases. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/IJMS242015165.","journal-title":"Int J Mol Sci."},{"key":"9949_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/apt.12859","volume":"40","author":"AJ Lucendo","year":"2014","unstructured":"Lucendo AJ, Arias \u00c1, Tenias JM. Systematic review: the association between eosinophilic oesophagitis and coeliac disease. Aliment Pharmacol Ther. 2014;40:422\u2013434.","journal-title":"Aliment Pharmacol Ther."},{"key":"9949_CR23","volume":"3","author":"N Mitselou","year":"2024","unstructured":"Mitselou N, Uchida A, Roelstraete B, Mel\u00e9n E, Garber JJ, Katzka D et al. Association of celiac disease with eosinophilic esophagitis: Nationwide register-based cohort study with sibling analyses. The Journal of Allergy and Clinical Immunology: Global. 2024;3:100254.","journal-title":"The Journal of Allergy and Clinical Immunology: Global."},{"key":"9949_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1017\/S0950268816003204","volume":"145","author":"A R\u00f6ckertTjernberg","year":"2017","unstructured":"R\u00f6ckertTjernberg A, Bonnedahl J, Inghammar M, Egesten A, Kahlmeter G, Naucl\u00e9r P et al. Coeliac disease and invasive pneumococcal disease: a population-based cohort study. Epidemiol Infect. 2017;145:1203.","journal-title":"Epidemiol Infect."},{"key":"9949_CR25","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.cgh.2023.01.029","volume":"21","author":"A Ford","year":"2023","unstructured":"Ford A, Chatterjee A, Lyu R, McMichael J, Jansson-Knodell C, Rubio-Tapia A. Increased risk of hospitalization in celiac disease with covid-19 infection is mitigated by vaccination. Clinical Gastroenterology and Hepatology. 2023;21:1485\u20131492.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9949_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14309\/ajg.0000000000002075","volume":"118","author":"A Rubio-Tapia","year":"2023","unstructured":"Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Lebwohl B. American College of gastroenterology guidelines update: diagnosis and management of celiac disease. American Journal of Gastroenterology. 2023;118:59\u201376.","journal-title":"American Journal of Gastroenterology."},{"key":"9949_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","volume":"54","author":"UR Hengge","year":"2006","unstructured":"Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1\u201315.","journal-title":"J Am Acad Dermatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09949-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09949-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09949-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:13:50Z","timestamp":1787800430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09949-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9949"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09949-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Claire Beveridge: consultant Takeda, Sanofi, GastroGirl, Guidepoint, Christopher Place Healthcare, Asofarma. The other authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study used de-identified data and was exempt from IRB review.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}